1,143
Views
11
CrossRef citations to date
0
Altmetric
Commentary

Peptide intra-tumor injection for cancer immunotherapy

Enhancement of tumor cell antigenicity is a novel and attractive strategy

, , &
Pages 1234-1236 | Received 31 Jan 2013, Accepted 13 Feb 2013, Published online: 14 Feb 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yuanfan Ye, Kevin J. Maroney, Howard W. Wiener, Olga A. Mamaeva, Anna D. Junkins, Greer A. Burkholder, Staci L. Sudenga, Mohd Khushman, Sameer Al Diffalha, Anju Bansal & Sadeep Shrestha. (2023) RNA-seq analysis identifies transcriptomic profiles associated with anal cancer recurrence among people living with HIV. Annals of Medicine 55:1.
Read now

Articles from other publishers (10)

Nian Liu, Xiangyu Xiao, Ziqiang Zhang, Chun Mao, Mimi Wan & Jian Shen. (2023) Advances in Cancer Vaccine Research. ACS Biomaterials Science & Engineering 9:11, pages 5999-6023.
Crossref
Mona O Mohsen, Matthew Heath, Matthias F Kramer, Thalia Carreno Velazquez, Alan Bullimore, Murray A Skinner, Daniel E Speiser & Martin F Bachmann. (2022) In situ delivery of nanoparticles formulated with micron-sized crystals protects from murine melanoma. Journal for ImmunoTherapy of Cancer 10:9, pages e004643.
Crossref
Dhatri Madduru, Ngalah Bidii Stephen, Urvashi Vijay, Pranathi Pappu, Prashanth Suravajhala & Obul Reddy Bandapalli. 2022. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3 225 243 .
Hadis Najafimehr, Nastaran Hajizadeh, Ehsan Nazemalhosseini-Mojarad, Mohamad Amin Pourhoseingholi, Meghdad Abdollahpour-Alitappeh, Sara Ashtari & Mohammad Reza Zali. (2020) The role of Human leukocyte antigen class I on patient survival in Gastrointestinal cancers: a systematic review and meta- analysis. Scientific Reports 10:1.
Crossref
Yasuhiro Shimizu, Toshiaki Yoshikawa, Takashi Kojima, Kayoko Shoda, Kazuto Nosaka, Shoichi Mizuno, Satoshi Wada, Yuki Fujimoto, Tetsuro Sasada, Kenichi Kohashi, Hideaki Bando, Itaru Endo & Tetsuya Nakatsura. (2019) Heat shock protein 105 peptide vaccine could induce antitumor immune reactions in a phase I clinical trial. Cancer Science 110:10, pages 3049-3060.
Crossref
Yasuhiro Shimizu, Toshihiro Suzuki, Toshiaki Yoshikawa, Itaru Endo & Tetsuya Nakatsura. (2019) Next-Generation Cancer Immunotherapy Targeting Glypican-3. Frontiers in Oncology 9.
Crossref
Yixin Yang, Christopher Alderman, Ayoub Sehlaoui, Yuan Xiao & Wei Wang. (2018) MicroRNAs as Immunotherapy Targets for Treating Gastroenterological Cancers. Canadian Journal of Gastroenterology and Hepatology 2018, pages 1-20.
Crossref
Q Liu, H Zhao, Y Jiang, M Wu, Y Tian, D Wang, Y Lao, N Xu & Z Li. (2016) Development of a lytic peptide derived from BH3-only proteins. Cell Death Discovery 2:1.
Crossref
Caglar Cekic, Yuan-Ji Day, Duygu Sag & Joel Linden. (2014) Myeloid Expression of Adenosine A2A Receptor Suppresses T and NK Cell Responses in the Solid Tumor Microenvironment. Cancer Research 74:24, pages 7250-7259.
Crossref
TOSHIAKI YOSHIKAWA, MASASHI TAKAHARA, MAI TOMIYAMA, MIE NIEDA, RYUJI MAEKAWA & TETSUYA NAKATSURA. (2014) Large-scale expansion of γδ T cells and peptide-specific cytotoxic T cells using zoledronate for adoptive immunotherapy. International Journal of Oncology 45:5, pages 1847-1856.
Crossref